William Swaim

individual · Philadelphia, Pennsylvania

lived:1781–1846

active:1820–1846

type:individual

role:promoter

location:Philadelphia, Pennsylvania

eventual status:publicly_disconfirmed

FINANCIAL CONFLICTS

Swaim was simultaneously the proprietor and a seller of the medicine whose universal cure claim and personal no-mercury safety pledge he authored and signed himself. He began as a bookbinder and switched to patent medicine in the 1820s, seeing in it a financial opportunity (Library Company of Philadelphia 2018). His 1828 printed notice to the public, bound into his own treatise, set the price at two dollars a bottle, described rising demand as the reason he could afford to lower that price, and carried his personal signature over a pledge that the medicine was free of mercury (Wellcome Collection, work bst63dyx). The Library Company's institutional profile records that he continued to accumulate wealth from the product even after the Philadelphia Medical Society had discredited it by 1829 (Library Company of Philadelphia 2018). The conflict named here is that his own income depended directly on sales of a remedy whose safety and universal efficacy he personally proclaimed in print; his accredited agents also sold it, so the conflict is his own direct financial dependence on the claims he authored, not exclusive command of every dollar the business made.

INTERVENTIONS PROMOTED

Swaim's Panacea

NOTES

William Swaim (1781-1846) began his working life as a bookbinder in Philadelphia and, in the 1820s, switched to patent medicine, launching Swaim’s Panacea around 1820 (Library Company of Philadelphia 2018; Young 1961). He marketed it as a purely vegetable preparation, free of mercury, capable of curing scrofula (King’s evil), mercurial and liver diseases, deep-seated syphilis, rheumatism, and any disorder arising from an impure state of the blood (Wellcome Collection, work bst63dyx). In a printed notice bound into his own 1828 treatise, priced at two dollars a bottle, Swaim personally pledged, over his own signature, that the medicine contained neither mercury nor any other deleterious drug (Wellcome Collection, work bst63dyx).

The Philadelphia Medical Society investigated the Panacea and, by 1828, had published a report Swaim contested in his own pamphlet the same year (Wellcome Collection, work avydpj7r; Young 1961). The Library Company of Philadelphia’s institutional profile records that Swaim had already been discredited by the Society by 1829, the year he purchased Library Company share number 439, and that he nonetheless continued to grow wealthy from the product (Library Company of Philadelphia 2018). Young’s academic history records that three separate chemists subsequently proved by analysis that Swaim’s sworn denial of mercury was false: at least some batches of the Panacea contained corrosive sublimate, one of the most severe common mercury compounds (Young 1961). Swaim died in 1846. The publicly_disconfirmed status recorded here attaches to Swaim’s own no-mercury safety claim and to the Society’s contemporaneous finding that the medicine was neither effective nor safe, not to any change in the business’s fortunes.